Macrophage-inflammatory protein-3α/CCL-20 is transcriptionally induced by the iron chelator desferrioxamine in human mononuclear phagocytes through nuclear factor (NF)-κB

Molecular Immunology

Volumn 47, Issue 4, 2010, Pages 685-693

  Varesio, Luigi ^a   Battaglia, Florinda ^a   Raggi, Federica ^a   Ledda, Bernadetta ^a   Bosco, Maria Carla ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Chemokines; Gene regulation; Inflammation; Iron chelation; Monocytes macrophages

Indexed keywords

DEFEROXAMINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TRANSCRIPTION FACTOR RELA;

ARTICLE; B LYMPHOCYTE; BINDING SITE; CONTROLLED STUDY; DENDRITIC CELL; DNA BINDING; DRUG MECHANISM; GENE INDUCTION; GENE MUTATION; HUMAN; HUMAN CELL; INFLAMMATION; IRON CHELATION; MEMORY T LYMPHOCYTE; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REGULATORY SEQUENCE; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ANIMALS; BINDING SITES; CELL HYPOXIA; CHEMOKINE CCL20; DEFEROXAMINE; DNA; HUMANS; IRON CHELATING AGENTS; MICE; MONOCYTES; NF-KAPPA B; PHAGOCYTES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 72949112224     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.10.031     Document Type: Article

References (69)

1. Baldwin C.L., Jiang X., and Fernandes D.M. Macrophage control of Brucella abortus: influence of cytokines and iron. Trends Microbiol. 1 (1993) 99-104
2. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 4 (2004) 540-550
3. Battaglia F., Delfino S., Merello E., Puppo M., Piva R., Varesio L., and Bosco M.C. Hypoxia transcriptionally induces macrophage-inflammatory protein-3{alpha}/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-{kappa}B. J. Leukoc. Biol. 83 (2008) 648-662
4. Bosco M.C., Delfino S., Ferlito F., Battaglia F.P.M., Gregorio A., Gambini C., Gattorno M., Martini A., and Varesio L. Hypoxic synovial environment and expression of macrophage inflammatory protein MIP-3α/CCL20 in Juvenile Idiopathic Arthritis. Arthritis Rheum. 58 (2008) 1833-1838
5. Bosco M.C., Puppo M., Blengio F., Fraone T., Cappello P., Giovarelli M., and Varesio L. Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 213 (2008) 733-749
6. Bosco M.C., Puppo M., Pastorino S., Mi Z., Melillo G., Massazza S., Rapisarda A., and Varesio L. Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J. Immunol. 172 (2004) 1681-1690
7. Bosco M.C., Puppo M., Santangelo C., Anfosso L., Pfeffer U., Fardin P., Battaglia F., and Varesio L. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J. Immunol. 177 (2006) 1941-1955
8. Bosco M.C., Rapisarda A., Massazza S., Melillo G., Young H., and Varesio L. The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage-inflammatory protein-1α and -1β in macrophages. J. Immunol. 164 (2000) 3283-3291
9. Brieva J.A., and Stevens R.H. Involvement of the transferrin receptor in the production and NK-induced suppression of human antibody synthesis. J. Immunol. 133 (1984) 1288-1292
10. Choi E.Y., Park Z.Y., Choi E.J., Oh H.M., Lee S., Choi S.C., Lee K.M., Im S.H., Chun J.S., and Jun C.D. Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-kappaB but involves ERK1/2- and p38 kinase-dependent activation of AP-1. J. Cell Biochem. 102 (2007) 1442-1457
11. Crapper Mc Lachet D., Dalton A., Hruck T., Bell M., Smith W., Kalow W., and Andrew D. Intramuscolar desferrioxamine in patients with Alzheimer's disease. Lancet 887 (1991) 1304-1308
12. Crichton R.R., and Ward R.J. Iron metabolism-new perspectives in view. Biochemistry 31 (1992) 11255-11264
13. Dlaska M., and Weiss G. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 162 (1999) 6171-6177
14. Donfrancesco A., Deb G., De Sio L., Cozza R., and Castellano A. Role of deferoxamine in tumor therapy. Acta Haematol. 95 (1996) 66-69
15. Fritsche G., Larcher C., Schennach H., and Weiss G. Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection. J. Infect. Dis. 183 (2001) 1388-1394
16. Fujiie S., Hieshima K., Izawa D., Nakayama T., Fujisawa R., Ohyanagi H., and Yoshie O. Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3alpha/CCL20 in mucosal epithelial cells through NF-kappaB [correction of NK-kappaB]. Int. Immunol. 13 (2001) 1255-1263
17. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl. (2002) S81-S96
18. Giardina P., and Grady R. Chelation therapy in beta-thalassemia: the benefits and limitation of desferrioxamine. Semin. Hematol. 32 (1995) 304-312
19. Golding S., and Young S.P. Iron requirements of human lymphocytes: relative contributions of intra- and extra-cellular iron. Scand. J. Immunol. 41 (1995) 229-236
20. Gray C.P., Arosio P., and Hersey P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 99 (2002) 3326-3334
21. Hamilton T.A., Ohmori Y., Tebo J.M., and Kishore R. Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines. Pathobiology 67 (1999) 241-244
22. Hayden M.S., West A.P., and Ghosh S. NF-kappaB and the immune response. Oncogene 25 (2006) 6758-6780
23. Imaizumi Y., Sugita S., Yamamoto K., Imanishi D., Kohno T., Tomonaga M., and Matsuyama T. Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha/CCL20 gene transcription via the NF-kappa B pathway. Int. Immunol. 14 (2002) 147-155
24. Jeong H.J., Chung H.S., Lee B.R., Kim S.J., Yoo S.J., Hong S.H., and Kim H.M. Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem. Biophys. Res. Commun. 306 (2003) 805-811
25. Kartikasari A.E., Visseren F.L., Marx J.J., van Mullekom S., Kats-Renaud J.H., Asbeck B.S., Ulfman L.H., and Georgiou N.A. Intracellular labile iron promotes firm adhesion of human monocytes to endothelium under flow and transendothelial migration Iron and monocyte-endothelial cell interactions. Atherosclerosis 205 (2008) 369-375
26. Kopydlowski K.M., Salkowski C.A., Cody M.J., Van Rooijen N., Major J., Hamilton T.A., and Vogel S.N. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J. Immunol. 163 (1999) 1537-1544
27. Kruck T., Fisher E., and Mc Lachten D. A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate. Clin. Pharmacol. Ther. 63 (1993) 30-37
28. Kwon J.H., Keates S., Simeonidis S., Grall F., Libermann T.A., and Keates A.C. ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3alpha gene expression in Caco-2 human colonic epithelial cells. J. Biol. Chem. 278 (2003) 875-884
29. Lee H.J., Choi S.C., Choi E.Y., Lee M.H., Seo G.S., Kim E.C., Yang B.J., Lee M.S., Shin Y.I., Park K.I., and Jun C.D. Iron chelator induces MIP-alpha/CCL20 in human intestinal epithelial cells: implication for triggering mucosal adaptive immunity. Exp. Mol. Med. 37 (2005) 297-310
30. Lee H.J., Lee J., Lee S.K., Lee S.K., and Kim E.C. Differential regulation of iron chelator-induced IL-8 synthesis via MAP kinase and NF-kappaB in immortalized and malignant oral keratinocytes. BMC Cancer 7 (2007) 176
31. Legssyer R., Josse C., Piette J., Ward R.J., and Crichton R.R. Changes in function of iron-loaded alveolar macrophages after in vivo administration of desferrioxamine and/or chloroquine. J. Inorg. Biochem. 94 (2003) 36-42
32. Lin R., Gewert D., and Hiscott J. Differential transcriptional activation in vitro by NF-kappa B/Rel proteins. J. Biol. Chem. 270 (1995) 3123-3131
33. Mair S.M., and Weiss G. New pharmacological concepts for the treatment of iron overload disorders. Curr. Med. Chem. 16 (2009) 576-590
34. Manzari B., Kudlow J.E., Fardin P., Merello E., Ottaviano C., Puppo M., Eva A., and Varesio L. Induction of macrophage glutamine: fructose-6-phosphate amidotransferase expression by hypoxia and by picolinic acid. Int. J. Immunopathol. Pharmacol. 20 (2007) 47-58
35. Marx J.J. Iron and infection: competition between host and microbes for a precious element. Best. Pract. Res. Clin. Haematol. 15 (2002) 411-426
36. Melillo G., Taylor L.S., Brooks A., Musso T., Cox G., and Varesio L. Functional requirement of the hypoxia responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272 (1996) 12236-12243
37. Muller P.Y., Janovjak H., Miserez A.R., and Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32 (2002) 1372-1379
38. Murdoch C., Giannoudis A., and Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104 (2004) 2224-2234
39. Nairz M., Fritsche G., Brunner P., Talasz H., Hantke K., and Weiss G. Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immunol. 38 (2008) 1923-1936
40. O'Brien-Ladner A.R., Blumer B.M., and Wesselius L.J. Differential regulation of human alveolar macrophage-derived interleukin-1beta and tumor necrosis factor-alpha by iron. J. Lab Clin. Med. 132 (1998) 497-506
41. Oexle H., Kaser A., Most J., Bellmann-Weiler R., Werner E.R., Werner-Felmayer G., and Weiss G. Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J. Leukoc. Biol. 74 (2003) 287-294
42. Pastorino S., Carta L., Puppo M., Melillo G., Bosco M.C., and Varesio L. Picolinic acid- or desferrioxamine-inducible autocrine activation of macrophages engineered to produce IFNgamma: an approach for gene therapy. Gene Ther. 11 (2004) 560-568
43. Pfaffl M.W., Tichopad A., Prgomet C., and Neuvians T.P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol. Lett. 26 (2004) 509-515
44. Philippe C., Roux-Lombard P., Fouqueray B., Perez J., Dayer J.M., and Baud L. Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: regulation by desferrioxamine. Immunology 80 (1993) 300-305
45. Potier E., Ferreira E., Dennler S., Mauviel A., Oudina K., Logeart-Avramoglou D., and Petite H. Desferrioxamine-driven upregulation of angiogenic factor expression by human bone marrow stromal cells. J. Tissue Eng. Regen. Med. 2 (2008) 272-278
46. Rapella A., Negrioli A., Melillo G., Pastorino S., Varesio L., and Bosco M.C. Flavopiridol inhibits vascular endothelial growth factor production induced by hypoxia or picolinic acid in human neuroblastoma. Int. J. Cancer 99 (2002) 658-664
47. Scaccabarozzi A., Arosio P., Weiss G., Valenti L., Dongiovanni P., Fracanzani A.L., Mattioli M., Levi S., Fiorelli G., and Fargion S. Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br. J. Haematol. 110 (2000) 978-984
48. Schall T.J., and Bacon K.B. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6 (1994) 865-873
49. Schutyser E., Struyf S., Menten P., Lenaerts J.P., Conings R., Put W., Wuyts A., Proost P., and Van Damme J. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells. J. Immunol. 165 (2000) 4470-4477
50. Schutyser E., Struyf S., and Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14 (2003) 409-426
51. Seligman P.A., Kovar J., and Gelfand E.W. Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways. Pathobiology 60 (1992) 19-26
52. Seligman P.A., Kovar J., Schleicher R.B., and Gelfand E.W. Transferrin-independent iron uptake supports B lymphocyte growth. Blood 78 (1991) 1526-1531
53. Seligman P.A., Schleicher R.B., Siriwardana G., Domenico J., and Gelfand E.W. Effects of agents that inhibit cellular iron incorporation on bladder cancer cell proliferation. Blood 82 (1993) 1608-1617
54. Simonart T., Boelaert J.R., Mosselmans R., Andrei G., Noel J.C., De Clercq E., and Snoeck R. Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells. Gynecol. Oncol. 85 (2002) 95-102
55. Simonart T., Degraef C., Andrei G., Mosselmans R., Hermans P., Van Vooren J.P., Noel J.C., Boelaert J.R., Snoeck R., and Heenen M. Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. J. Invest. Dermatol. 115 (2000) 893-900
56. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., and Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175 (2005) 342-349
57. Sugita S., Kohno T., Yamamoto K., Imaizumi Y., Nakajima H., Ishimaru T., and Matsuyama T. Induction of macrophage-inflammatory protein-3alpha gene expression by TNF-dependent NF-kappaB activation. J. Immunol. 168 (2002) 5621-5628
58. Tahara K., Nishiya K., Hisakawa N., Wang H., and Hashimoto K. Suppressive effect of iron on concanavalin A-induced multinucleated giant cell formation by human monocytes. Immunol. Invest. 32 (2003) 229-243
59. Tanji K., Imaizumi T., Matsumiya T., Itaya H., Fujimoto K., Cui X., Toki T., Ito E., Yoshida H., Wakabayashi K., and Satoh K. Desferrioxamine, an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line. Biochim. Biophys. Acta 1530 (2001) 227-235
60. Theurl I., Aigner E., Theurl M., Nairz M., Seifert M., Schroll A., Sonnweber T., Eberwein L., Witcher D.R., Murphy A.T., Wroblewski V.J., Wurz E., Datz C., and Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113 (2009) 5277-5286
61. Varesio L., Espinoza-Delgado I., Gusella G., Cox G., Melillo G., Musso T., and Bosco M.C. Role of cytokines in the activation of monocytes. In: Aggarwal B.B., and Puri R.K. (Eds). Human Cytokines: Their Role in Disease and Therapy (1995), Blackwell Scientific Publication, Inc., Cambridge, MA 55-70
62. Wang G., and Semenza G. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications of models of hypoxia signal transduction. Blood 82 (1993) 3610-3615
63. Ward R.J., Wilmet S., Legssyer R., and Crichton R.R. The influence of iron homoeostasis on macrophage function. Biochem. Soc. Trans. 30 (2002) 762-765
64. Weinberg E.D. Iron availability and infection. Biochim. Biophys. Acta 1790 (2009) 600-605
65. Weinberg E.D., and Miklossy J. Iron withholding: a defense against disease. J. Alzheimers Dis. 13 (2008) 451-463
66. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim. Biophys. Acta 1790 (2009) 682-693
67. Weiss G., Wachter H., and Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol. Today 16 (1995) 495-500
68. Williams A., and Meyer D. Desferrioxamine as immunomodulatory agent during microorganism infection. Curr. Pharm. Des. 15 (2009) 1261-1268
69. Woo K.J., Lee T.J., Park J.W., and Kwon T.K. Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway. Biochem. Biophys. Res. Commun. 343 (2006) 8-14